Vaccine and Treatment Evaluation Units: A Historical Perspective
Clinical Infectious Diseases · 2025
DOI: 10.1093/cid/ciaf454 ↗Kurz gefasst
Historischer Beitrag in der Zeitschrift Clinical Infectious Diseases, 2025. Verfasst von Robert B Belshe und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Vaccine Development, Saint Louis University, Saint Louis, Missouri, USA. Hauptthemen laut MEDLINE: Vaccine Development, Vaccines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 243 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
On 27 February 1962, Surgeon General Luther Terry announced a new vaccine development program within the National Institute of Allergy and Infectious Diseases (NIAID). Initially, the plan had three components: (1) special laboratories and facilities for development of prototype vaccines; (2) pilot lot production facilities and preliminary vaccine trial sites; and (3) larger lot production capacity and expanded human testing. Respiratory viruses were targeted as the top priority for vaccine development. Over 5 decades, this program has evolved and expanded to include multiple academic vaccine evaluation sites within the network, now labeled as the Vaccine and Treatment Evaluation Units (VTEUs). The network has evaluated many different vaccines, with many shown to be safe, effective, and licensed for recommended use. This manuscript offers a historical perspective, crafted by early investigators from currently funded VTEUs, to showcase how some of the original VTEUs—both individually and collectively—advanced vaccine science and shaped the strategies and achievements that continue to impact public health today.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Vaccine Development, Saint Louis University, Saint Louis, Missouri, USA.
- Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio, USA.
- Vanderbilt Vaccine Research Program, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
- Vanderbilt Vaccine Research Program.
- Molecular Virology & Microbiology and Medicine, Baylor College of Medicine, Houston, Texas, USA.
- Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
ORCID-Profile: Robert B Belshe, David I Bernstein, Kathryn M Edwards, Sharon E Frey, Wendy A Keitel
Förderung
- NIAID NIH HHS
Zitieren
APA
Belshe, R. B., Bernstein, D. I., Edwards, K. M., Frey, S. E., Keitel, W. A., Levine, M. M., Treanor, J. J., & Wright, P. F. (2025). Vaccine and Treatment Evaluation Units: A Historical Perspective. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf454
Vancouver
Belshe RB, Bernstein DI, Edwards KM, Frey SE, Keitel WA, Levine MM, et al. Vaccine and Treatment Evaluation Units: A Historical Perspective. Clinical Infectious Diseases. 2025. doi:10.1093/cid/ciaf454
BibTeX
@article{Belshe2025,
author = {Belshe, Robert B and Bernstein, David I and Edwards, Kathryn M and Frey, Sharon E and Keitel, Wendy A and Levine, Myron M and Treanor, John J and Wright, Peter F},
title = {Vaccine and Treatment Evaluation Units: A Historical Perspective},
journal = {Clinical Infectious Diseases},
year = {2025},
doi = {10.1093/cid/ciaf454}
}
EUVIMED